Capstone Partners served as exclusive financial advisor to C.B.
Fleet Company, Inc. (“Fleet Laboratories”), a leading manufacturer and marketer of consumer branded, OTC health and personal care products, in its sale to Gryphon Investors, a San Francisco-based private equity firm.
Fleet Laboratories owns a portfolio of iconic brands in the feminine hygiene, gastrointestinal care and infant care categories including Summer’s Eve®, Fleet®, Pedia-Lax®, Phazyme® and Boudreaux’s®.
The Company’s products, which are sold in over 50 countries worldwide, have an unmatched legacy of trust and efficacy with consumers and medical professionals.
Fleet Laboratories’ sales and marketing expertise as well as its full service operational capabilities position the Company as a strong platform for growth.
Gryphon Investors, with over $1.4 billion of cumulative equity commitments, focuses on acquisitions of middle-market companies in partnership with experienced management teams to build leading companies.
This is the fourth transaction Capstone Partners has completed for Fleet Laboratories.
Once you have made the difficult decision to sell a 145-year-old family business with global reach and over 60 shareholders, your next step is to retain a first class financial advisor who understands your company and its industry, which has deep experience in M&A transactions and, most importantly, whom you can trust implicitly. [Capstone Partners] has been our go-to banker for strategic transactions for the past 20 years, while also providing consistent guidance on a host of financial issues. For the Board of Directors of C.B. Fleet, selecting [Capstone] was an easy decision.
